Differences in Growth Properties among Two Human Cytomegalovirus Glycoprotein O Genotypes by Kalser, Julia et al.
fmicb-08-01609 August 19, 2017 Time: 16:2 # 1
ORIGINAL RESEARCH
published: 22 August 2017
doi: 10.3389/fmicb.2017.01609
Edited by:
Michael Nevels,
University of St Andrews,
United Kingdom
Reviewed by:
Giorgio Gribaudo,
University of Turin, Italy
Tatsuo Suzutani,
Fukushima Medical University, Japan
*Correspondence:
Irene Görzer
irene.goerzer@meduniwien.ac.at
Specialty section:
This article was submitted to
Virology,
a section of the journal
Frontiers in Microbiology
Received: 10 April 2017
Accepted: 07 August 2017
Published: 22 August 2017
Citation:
Kalser J, Adler B, Mach M, Kropff B,
Puchhammer-Stöckl E and Görzer I
(2017) Differences in Growth
Properties among Two Human
Cytomegalovirus Glycoprotein O
Genotypes. Front. Microbiol. 8:1609.
doi: 10.3389/fmicb.2017.01609
Differences in Growth Properties
among Two Human Cytomegalovirus
Glycoprotein O Genotypes
Julia Kalser1, Barbara Adler2, Michael Mach3, Barbara Kropff3,
Elisabeth Puchhammer-Stöckl1 and Irene Görzer1*
1 Center for Virology, Medical University of Vienna, Vienna, Austria, 2 Max von Pettenkofer-Institute for Virology,
Ludwig-Maximilians-University Munich, Munich, Germany, 3 Institute of Clinical and Molecular Virology, Friedrich-Alexander
University Erlangen-Nürnberg, Erlangen, Germany
Glycoprotein O (gO) of the human cytomegalovirus (HCMV) is the critical subunit
of the envelope trimer gH/gL/gO as it interacts with platelet-derived growth factor
alpha receptor upon fibroblast entry, and triggers gB-mediated fusion for fibroblast
and epithelial cell infection. Eight genotypes (GT) of the highly polymorphic gO gene
are described, yet it is unclear whether the distinct GTs differ in their function. Thus,
we aimed to elucidate potential functional differences between two highly diverse gO
GTs in an otherwise genomically identical HCMV strain. Therefore, resident gO GT1c
sequence of strain TB40-BAC4-luc was entirely replaced by gO GT4 of strain Towne
and both, GT1c and GT4 viruses, were investigated for their growth properties in
fibroblasts and epithelial cells. In addition, two conserved gO cysteines involved in
gH/gL/gO stabilization were mutated to serine either in GT1c (C218S and C343S)
or GT4 (C216S and C336S) and their effects on cell-free infectivity were assessed.
GT4 viruses displayed a significantly enhanced epithelial cell tropism and this resulted
in higher virus release upon replication in epithelial cells when compared to GT1c
viruses. Further, when the two cysteines were individually mutated in gO GT1c no
impairment in cell-free infectivity was observed. This, however, was in sharp contrast
to gO GT4, in which both of the corresponding cysteine mutations led to a substantial
reduction in cell-free infectivity which was even more pronounced upon mutation of
GT4-C336 than of GT4-C216. In conclusion, these findings provide evidence that the
two highly diverse gO genotypes, GT1c and GT4, differ in their functional properties as
revealed by their different infection capacities for epithelial cells and by their different
responsiveness to mutation of strictly conserved cysteine residues. Thus, it is likely that
the gO heterogeneity influences cell-free infectivity of HCMV also in vivo which may have
important implications for virus host transmission.
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INTRODUCTION
Human cytomegalovirus (HCMV) is a ubiquitously distributed human betaherpesvirus with
40–90% of adults infected worldwide. HCMV infection in immunocompetent individuals is usually
clinically silent, but may lead to severe clinical manifestations in congenitally infected newborns
and is one of the most severe opportunistic viral infections in patients with a weakened immune
system (Britt, 2008; Mocarski, 2013).
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Human cytomegalovirus has a large dsDNA genome with about
236 kb coding for ∼165 genes (Dolan et al., 2004; Sijmons
et al., 2014). Comprehensive sequence analysis of numerous
HCMV strains showed that a subset of genomic regions, which
often encode for genes involved in immunomodulation, entry,
spread, and cell tropism, is particularly diverse (Dunn et al.,
2003; Stern-Ginossar et al., 2012; Van Damme and Van Loock,
2014). Remarkably, for most of the polymorphic genes a limited
number of genotypes can be defined and it appears that
extensive recombinations between HCMV strains have led to
a large variety of circulating HCMV strains differing in their
genotypic combinations (Dolan et al., 2004; Puchhammer-Stöckl
and Görzer, 2011; Sijmons et al., 2015).
Human cytomegalovirus infects a broad range of cell types
in vivo, with epithelial cells, endothelial cells, fibroblasts and
smooth muscle cells being the predominant targets for virus
replication (Sinzger et al., 2008; Mocarski, 2013). Two envelope
glycoprotein complexes, the trimer gH/gL/gO and the pentamer
gH/gL/UL128L, seem to play an important role in cell tropism
(Ryckman et al., 2010; Wille et al., 2010; Scrivano et al., 2011).
Since both, gO and UL128, form a covalent bond with gL-C144
of the gH/gL heterodimer, the two complexes are mutually
exclusive (Ciferri et al., 2015; Zhou et al., 2015). The current
model proposes that the trimer is necessary for entry in all cell
types while the pentamer is additionally required for entry into
epithelial and endothelial cells (Jiang et al., 2008; Wille et al.,
2010; Kabanova et al., 2016), and it is further suggested that the
relative amounts of both complexes define the cell tropism of
virus progenies (Murrell et al., 2013; Zhou et al., 2013, 2015; Laib
Sampaio et al., 2016).
When comparing the gene sequences coding for the subunits
of the two complexes, it is striking that solely the gO gene shows a
high level of variation among different HCMV strains, clustering
into eight distinct gO genotypes (GT). The codon sequence
diversity between genotypes ranges from 11 to 24%, but the intra-
genotype diversity is less than 2%. The most variable regions
are the N-terminus and the central part, and the full length of
gO varies between 457 and 472 amino acid residues (Paterson
et al., 2002; Rasmussen et al., 2002; Mattick et al., 2004; Stanton
et al., 2005). It appears that gO gene-disrupting mutations do
not emerge in HCMV strains present in clinical isolates (Sijmons
et al., 2015). Furthermore, the different gO genotypes have been
found in clinical isolates from diverse geographical locations and
in different disease backgrounds, either emerging as a single
genotype or a gO genotype mixture (Rasmussen et al., 2002,
2003; Mattick et al., 2004; Stanton et al., 2005; Puchhammer-
Stöckl et al., 2006; Bates et al., 2008; Yan et al., 2008; Sowmya
and Madhavan, 2009; Görzer et al., 2010, 2015; Chen et al., 2016).
This strongly suggests that all distinct gO genotypes are able to
fulfill their in vivo function given that the integrity of the protein
is not disturbed. This is well consistent with the notion that all gO
genotypes form stable gH/gL/gO complexes when reconstructed
by Ad vector expression (Zhou et al., 2013).
In cell-culture adapted HCMV strains a deletion of gO causes
severe reduction in cell-free infectivity on fibroblasts, epithelial,
and endothelial cells (Hobom et al., 2000; Dunn et al., 2003;
Jiang et al., 2008; Wille et al., 2010), but it has little effect on
focal cell-associated spread in the background of HCMV strain
Merlin which resembles clinical isolates (Laib Sampaio et al.,
2016), indicating that gO plays a particular important role in
cell-free infectivity. Since monoclonal anti-gO antibodies are able
to neutralize both fibroblast and epithelial cell infection (Gerna
et al., 2016; Kabanova et al., 2016), it is suggested that gO is
the critical subunit of the trimer, either for interaction with
the recently identified fibroblast-specific platelet-derived growth
factor alpha receptor (PDGFRα), or for activation of gB-mediated
fusion (Schultz et al., 2015; Zhou et al., 2015).
So far, little is known about how the distinct gO genotypes
may differ in their function. First evidence came from a study
by Paterson et al. (2002) in which they suggested that the
sensitivity of focal growth to neutralizing gH antibodies depends
on differences in the gO gene. And recently, by analyzing
extracellular virions deriving from different HCMV strains, it
was proposed that the gO diversity may affect the trimer to
pentamer ratio in the virus envelope with potential consequences
on HCMV tropism and clinical pathology (Zhou et al., 2013).
In the present study, we aimed to elucidate whether distinct
HCMV gO genotypes in an otherwise genetically identical
strain background differ in their growth properties. To answer
this question we chose two highly diverse gO genotypes for
comparison, gO GT1c of HCMV strain TB40E and gO GT4 of
strain Towne, which differ by 22% at the amino acid level. First,
full-length of gO GT1c of the parental strain TB40-BAC4-luc
was exchanged by gO GT4. Second, in these two different gO
genotypic backgrounds two strictly conserved cysteine residues
were mutated individually and in combination, to generate a
set of gO cysteine mutants. Assessment of infection and growth
of parental and mutant viruses in fibroblasts and epithelial
cells revealed significant differences between GT1c and GT4 in
epithelial cell tropism and in the phenotypic manifestation of
cysteine point mutations.
MATERIALS AND METHODS
Cells
Human foreskin fibroblasts were cultured in minimum
essential medium Eagle (MEM; Sigma–Aldrich, St. Louis, MO,
United States) supplemented with 10% heat-inactivated fetal
bovine serum (FBS; Gibco Thermo Fisher, Waltham, MA,
United States) and 0.5% neomycin (Sigma–Aldrich). Human
adult retinal pigmented epithelial cells (ARPE-19; ATCC,
Manassas, VA, United States) were cultured in Dulbecco’s
modified Eagle medium/nutrient mixture F12 (PAN-Biotech,
Aidenbach, Germany) supplemented with 10% FBS and 1%
penicillin-streptomycin (Thermo Fisher).
Viral Mutagenesis
The gO genotype (GT) 4 mutants were generated using the
HCMV strain TB40/E as parental strain that was cloned in a
bacterial artificial chromosome (BAC) sequence [TB40-BAC4-
luc; (Scrivano et al., 2011)]. By “en passant” mutagenesis in
Escherichia coli GS1783 (Tischer et al., 2010), the glycoprotein
O (gO) sequence of the parental strain (gO GT1c) was fully
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exchanged by gO GT4. For this, a marker cassette was amplified
from pEP-Kan-S (kindly provided by N. Osterrieder) by PCR
using primer pair 1 (see Supplementary Table 1). The cassette
contained a kanamycin resistance gene, flanked on one site by
an 18-bp I-Sce I restriction sequence and a gO GT-specific
50-bp sequence, and on both sites by a Sac I restriction site.
A plasmid containing the gO GT4 sequence, interrupted by the
previously mentioned 50-bp sequence and a Sac I restriction
site was ordered from Eurofins Genomics (Luxembourg). The
marker cassette and the plasmid were cut with Sac I and ligated.
From the resulting transfer plasmid, a recombination cassette
was generated by PCR using primer pair 2 (see Supplementary
Table 1). The recombination cassette contained extensions of
∼50 bp sequences on each end, which were homologous to
the site of insertion in the TB40-BAC-luc genome. The transfer
cassette was electroporated into recombination-competent E. coli
GS1783 carrying the TB40-BAC4-luc genome. For generation
of cysteine mutants, single cysteines within gO of GT1c and
GT4 were mutated to serine. For this, a recombination cassette
was generated directly from pEP-Kan-S as described above. The
cassette contained the sequence duplication necessary for red
recombination and the gO GT-specific sequence harboring the
cysteine mutation, and was electroporated into E. coli GS1783
carrying either the TB40-BAC4-luc genome or the TB40-BAC4-
luc-gO GT4 genome. Single mutants were further used to
generate double cysteine mutants by the described method. After
electroporation, recombination-positive E. coli were subjected to
kanamycin selection, and the introduced non-HCMV sequences
were removed within E. coli by cleavage at the I-Sce I site and
a second red recombination. Positive, i.e., kanamycin-sensitive,
bacteria were selected, and overnight cultures were stored at
−80◦C until further use. Mutant BACs were confirmed by
sequencing.
Viral Reconstitution
Bacterial artificial chromosome-DNA was purified from E. coli
using the Nucleobond BAC100 kit (Macherey-Nagel, Düren,
Germany). The pp71-encoding plasmid pCMV71 (kindly
provided by Mark Stinski, University of Iowa) was transformed
into NEB10-beta competent E. coli (New England Biolabs,
Ipswich, MA, United States) by heat-shock, and subsequently
purified from overnight cultures using Qiaprep Spin Miniprep
kit (Qiagen, Hilden, Germany). For transfection, HFFs were
seeded in 6-well plates (3 × 105 cells/well). The following day,
2 µg of BAC DNA and 1 µg of pCMV71 DNA were mixed
together with 9 µl of ViaFect reagent (Promega, Madison, WI,
United States) and 100 µl of MEM. The mixture was incubated
for 15 min at room temperature and then added to the cells,
which were incubated further at 37◦C. 24 h after transfection,
cells were washed with PBS and fresh MEM was added. One
week after transfection, cells were trypsinized and transferred
into 75 cm2 cell culture flasks. Cells were screened regularly by
light microscopy for the appearance of cytopathic effect (CPE),
and supernatants were tested for HCMV-DNA load by qPCR.
When CPE was 90–100%, supernatants were centrifuged at
room temperature for 20 min at 4000 × g. Of note, CPE of gO
GT4-C336S remained restricted to single foci even after HFFs
were detached by trypsin and reseeded two times during the
course of reconstitution (at days 13 and 18 post transfection)
to enhance viral spread. Thus, for gO GT4-C336S virus stocks
were harvested when similarly high HCMV-DNA levels were
reached. Cleared supernatants, containing virus particles, were
stored as viral stocks in aliquots at −80◦C, before further usage
for infection and replication analyses. All stocks were subjected
to whole genome sequencing.
DNA Extraction
In order to remove non-encapsidated viral DNA and free cellular
DNA, viral stocks and cell culture supernatants were treated with
Turbo DNase (Thermo Fisher). For this, 100 µl of master mix
(73 µl H2O, 20 µl 10x DNase buffer, 5 µl 10x PBS, 2 µl Turbo
DNase (2 µ/µl)) were added to 100 µl of sample and incubated
for 1 h at 37◦C in a thermoshaker at 1400 rpm. Thereafter, 2 µl
of Protease (100 mg/ml, Qiagen) were added and incubated for
30 min at 37◦C in a thermoshaker at 1400 rpm. Viral or cellular
DNA was extracted from DNase-treated samples or from non-
treated cell suspensions using the bead-based NucliSens EasyMag
extractor (BioMérieux, Marcy-l’Étoile, France). DNA was eluted
in 50 µl of nuclease-free H2O.
qPCR
For quantification of viral genomes, a region within US17
of the HCMV genome was amplified using the forward
primer GCGTGCTTTTTAGCCTCTGCA (10 pM), the reverse
primer AAAAGTTTGTGCCCCAACGGTA (10 pM), and the
TaqMan probe FAM-TGATCGGCGTTATCGCGTTCTTGATC-
TAMRA (2 pM). For quantification of cellular genomic DNA
(gDNA), a region within the human beta-2-microglobulin gene
was amplified using the forward primer TGAGTATGCCTG
CCGTGTGA (3 pM), the reverse primer ACTCATACACAACTT
TCAGCAGCTTAC (3 pM), and the TaqMan probe FAM-CCA
TGTGACTTTGTCACAGCCCAAGATAGTT-TAMRA (1 pM).
Primers and probe (all TIB Molbiol, Berlin, Germany) were
mixed with 12.5 µl of TaqMan Universal PCR Master Mix
(Applied Biosystems, Foster City, CA, United States) to a
volume of 20 µl, which were added to 5 µl of extracted
DNA for amplification. PCR amplicons were detected using
the ABI 7300 real-time PCR system (Applied Biosystems). The
results were compared to an HCMV standard (strain AD169;
Advanced Biotechnologies Inc., Eldersburg, MD, United States)
and calculated as genome copies/ml. A defined number of human
cells was used as standard for calculation of cellular genomic
DNA (gDNA).
Fifty Percent Tissue Culture Infective
Dose (TCID50) Limiting Dilution Assay
For determination of infectious viral titer, limiting dilution assay
was performed. HFFs were seeded in 96-well plates (1 × 104
cells/well) and infected with serial dilutions of viral stock or cell
culture supernatant in eight replicates per dilution. 14 days after
infection, cells were screened by light microscopy for CPE, and
viral titers were calculated as TCID50/ml by the Reed–Muench
method.
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FIGURE 1 | Growth curves and genome dynamics of gO GT1c and gO GT4. Fibroblasts (HFF) and epithelial cells (ARPE-19) were infected with two clones each of
gO GT1c and GT4 at an MOI of 0.1 and cultured for 12 days. At the indicated time points, viral titer [TCID50/ml on fibroblasts; (A,C)] and cell-free viral load [HCMV
DNA copies/ml (B,D)] of cell culture supernatants were assessed. Error bars indicate SD from three replicates.
Infection Efficiency
Human foreskin fibroblasts and ARPE-19 cells were seeded
in white, clear, flat-bottom 96-well plates (Corning, Corning,
NY, United States) at a density of 1 × 104 cells/well. The
following day, viral stocks were treated with DNase as described
above, the number of encapsidated genomes of each aliquot
was determined by qPCR, and the stocks diluted to the
indicated concentrations in cell culture medium; 100 µl of viral
dilution per well were used to infect the cells in triplicates
for 2 h at 37◦C. (MOI of 1 corresponds to 3.59 × 108
encapsidated genomes/ml in gO GT1c). Cells were washed
three times with PBS, supplied with 100 µl of medium or
medium supplemented with 300 µg/ml of phosphonoacetic acid
(PAA; Sigma–Aldrich) and incubated further at 37◦C. 48 h post
infection, luciferase assay of cell lysates was performed according
to the manufacturer’s protocol (Steady-Glo Luciferase Assay
System, Promega) and relative light units (RLU) were measured
in a Victor Light 1420 plate reader (PerkinElmer, Waltham, MA,
United States). Mean RLUs of triplicates were calculated for
evaluation.
Replication Efficiency
One day prior to infection, HFFs and ARPE-19 were seeded in
24-well plates at a density of 1 × 105 cells/well. Viral stocks
were diluted in the appropriate cell culture medium. In Figure 1
cells were infected with an MOI of 0.1. In Figure 5 initial
infectivity was normalized for each strain to yield 500–1500
RLUs at 48 h post infection. Cells were infected with the RLU-
adjusted viral dilutions, and 48 h post infection the RLUs were
again determined to confirm normalized infectivity of all strains
(see Supplementary Table 1). In Supplementary Figure 1 cells
were infected with the same number of encapsidated genomes
(3.59 × 107/ml) corresponding to an MOI of 0.1 of gO GT1c. In
each experiment cells were infected in triplicates for 2 h at 37◦C,
washed three times with PBS and supplied with 1 ml of medium.
Supernatants and cells were harvested separately at indicated
time points over a time course of 2 weeks. Viral load and human
genomic DNA (gDNA) were determined by qPCR. For cell-
associated viral DNA, viral genomes were normalized to the same
copy number of human gDNA. Growth curves were generated by
assessing viral titers (TCID50/ml) of cell-free supernatants at the
indicated time points.
Whole Genome Sequencing
DNA from BAC purification (as described above) and
extracted DNA from DNase-treated viral stocks and cell
culture supernatants were quantified using the Qubit 2.0
fluorometer (Thermo Fisher) according to the manufacturer’s
instructions. One to 2 ng of DNA per sample were taken
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for library preparation using the Nextera XT DNA Library
Preparation Kit and uniquely indexed samples using the Nextera
XT Index Kit were pooled and sequenced together. Pooled
libraries were sequenced with paired-end reads (2 × 150–250)
on a MiSeq system (Illumina, San Diego, CA, United States).
Data were analyzed by CLC genomics workbench 8 software
(Qiagen). Average >Q30 score ranged between 66 and 92%
of reads, with average 867-fold coverage. Low-quality reads
were trimmed before alignment to the respective reference
sequence.
Viral Stocks for Immunoblotting
For immunoblotting, supernatants from infected HFFs were
harvested when cells displayed ∼90% CPE. Supernatants were
precleared from cellular debris by centrifugation for 10 min at
4000 × g, before centrifugation for 80 min at 70000 × g at
10◦C. The virion pellets were resuspended in TAN buffer (0.05 M
triethanolamine, 0.1 M NaCl, pH 8) on ice, and stored in aliquots
at−80◦C.
Immunoblotting
For sample preparation, virus stocks were mixed undiluted
or diluted in TAN buffer with an equal volume of reducing
2x sample buffer (125 mM Tris/Cl pH 6.8, 6% SDS, 10%
glycerol, 10% 2-mercaptoethanol, 0.01% bromophenol blue)
and incubated on ice for 10 min before boiling at 95◦C for
10 min. Samples were separated on 10% SDS PAGE gels
together with a high-range rainbow marker (Amersham ECL
High-Range Rainbow Molecular Weight Marker, GE Healthcare,
United Kingdom). Separated proteins were transferred to
polyvinylidene difluoride (PVDF) membranes (Immun-Blot,
Bio-Rad, Richmond, CA, United States) in blotting buffer
(40 mM Tris, 39 mM glycine, 1.3 mM SDS, 20% methanol),
which were than incubated overnight in blocking buffer (PBS,
1% BSA, 0.1% Tween-20) at 4◦C. All antibodies were diluted
in blocking buffer. Primary mouse anti-major capsid protein
(MCP) mAb, anti-gH (AP86-SA4) mAb (both kindly shared
by Michael Mach), and anti-gO.02 mAb (kindly provided by
Barbara Adler) were incubated for 2 h at RT. Sheep, anti-
mouse IgG-HRP (Amersham, GE Healthcare, United Kingdom)
was used as secondary antibody and incubated for 1 h at
RT. SuperSignal West Femto Maximum Sensitivity substrate
(Thermo Fisher) was applied to the membranes according to
the manufacturer’s instructions. Chemiluminescent signals were
visualized and analyzed using the ChemiDoc Imager and the
Image Lab 6.0 software (both Bio-Rad).
Statistical Analyses
Relative epithelial cell tropism between parental and mutant
gO strains (Figure 2), and fibroblast and epithelial cell
infectivity of cysteine mutants compared to their parental strains
(Figure 3) were analyzed by unpaired two-tailed t-test. To
compare infectivity between the two GT1c clones and two GT4
clones (Figure 3), differences in mean RLUs were analyzed
by one-way ANOVA test. Mean values from three to eight
independently repeated experiments were used for statistical
analyses. P-values < 0.05 were considered significant. GraphPad
Prism version 7.01 was used for statistical analyses.
RESULTS
Generation of BAC-Derived HCMV
Strains Differing Only in the gO Genotype
Sequences
To investigate whether the exclusive exchange of the full-length
open reading frame (ORF) of gO with a different genotype
sequence influences the growth properties of HCMV, the gO
GT4 mutant was generated. We used the BAC clone TB40-
BAC4-luc as parental strain to seamlessly replace its resident
gO GT1c sequence by gO GT4. As previously reported, TB40-
BAC4-luc (from now on termed gO GT1c) carries a luciferase
expression cassette which allows a sensitive and quantitative
measurement of infection over a wide range of multiplicities
of infection (MOI) (Scrivano et al., 2011). After “en passant”
mutagenesis the genomic integrity of two resulting viral BAC-
mutant gO GT4 clones (Table 1 and Supplementary Table 1)
which showed complete replacement of GT1c ORF (464 aa)
by GT4 ORF (457 aa) was confirmed by whole genome
deep sequencing. Reconstitution of gO GT1c and gO GT4
mutant BAC clones in HFFs resulted in infectious viruses
with similarly high TCID50 and similar copy numbers of
encapsidated viral genomes (Table 1). Both, gO GT1c and
gO GT4 induced the characteristic HCMV CPE, with even
distribution over the entire HFF monolayer. Hence, full-length
replacement of gO GT1c by GT4 sequence allowed the generation
of infectious virus particles upon reconstitution in HFFs.
Whole HCMV genome sequencing of both gO GT1c (GT1c_1
and GT1c_2) and gO GT4 mutant virus stocks (GT4_1 and
GT4_2) confirmed that no additional mutations emerged during
reconstitution.
Multi-Step Growth Curve Analysis of gO
GT1c and gO GT4 Mutants in Fibroblasts
and Epithelial Cells
TB40E-derived strain TB40-BAC4-luc is able to infect and
replicate in a broad range of different cell types including
fibroblasts and epithelial cells (Scrivano et al., 2011). To compare
the replication efficiencies of the two HFF-derived gO GT4
mutants, GT4_1 and GT4_2, with that of two independently
generated HFF-derived gO GT1c virus stocks (GT1c_1 and
GT1c_2), HFFs and ARPE-19 cells were infected at an MOI of 0.1.
Over a time course, the production of cell-free infectious virus
was assayed by limiting dilution assay (TCID50) and the amount
of HCMV-DNA in supernatant was determined by HCMV-
specific qPCR. As shown in Figure 1, in HFFs both gO GT4
mutants displayed similar release of cell-free infectious virus and
HCMV-DNA load in comparison to the two gO GT1c viruses.
Also, the endpoint titers (Figure 1A) and endpoint HCMV-
DNA levels were similarly high in gO GT1c and gO GT4 strains
(Figure 1B). In ARPE-19 cells, however, both gO GT4 clones
produced 0.89–1.36 log10 TCID50/ml higher endpoint titers than
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FIGURE 2 | Relative epithelial cell tropism of gO GT1c and gO GT4 mutants. Fibroblasts (HFF) and epithelial cells (ARPE-19) were infected in triplicates with two
clones each of gO GT1c and GT4 at low MOIs from 0.1 to 0.4 for 2 h, and incubated for further 46 h in the presence (A,B) or absence (C,D) of phosphonoacetic
acid (PAA). The HFF infection capacity was set to 100% and the epithelial cell infection capacity was determined proportionally. Relative light units (RLU) were
determined in triplicates. Mean values from three to six independent experiments are shown in the upper panels, error bars indicate SD. ∗p < 0.05, ∗∗p < 0.01,
∗∗∗p < 0.001, unpaired two-tailed t-test. In the lower panels (B,D), three single representative assays for each PAA+ and PAA– are shown.
the gO GT1c clones (Figure 1C). In overall, the HCMV-DNA
load kinetics in supernatant paralleled the kinetics of cell-free
virus production (Figure 1D).
These findings demonstrate that despite replacement of the
entire resident gO gene sequence of TB40-BAC4-luc by a different
gO gene sequence, the resulting viruses retained the growth
capacity in different cell types.
Relative Epithelial Cell Tropism of gO
GT1c and gO GT4 Mutants
As gO GT4 displayed a subtle enhancement for growth in
ARPE-19 cells compared to GT1c the relative epithelial cell
tropism was explored. Therefore, HFFs and ARPE-19 cells were
synchronously infected at a low MOI (0.1–0.4) by gO GT1c and
gO GT4, and after 48 h cell lysates were assayed for expression
of luciferase as indicator for viral infection. A number of
independent experiments was performed either with or without
the replication inhibitor PAA. In each experiment RLUs were
determined in triplicates and the ARPE-19 to HFF infection
ratio in percent was determined. As shown in Figure 2, each
of the two gO GT4 mutant viruses, GT4_1 and GT4_2, showed
a higher epithelial cell tropism compared to gO GT1c viruses
GT1c_1 and GT1c_2. In the presence of PAA (Figure 2A) the
epithelial cell tropism was significantly increased for GT4_1 when
compared to GT1c_1 (p = 0.0292), and for both GT4_1 and
GT4_2 when compared to GT1c_2 (p = 0.0148 and 0.0169,
respectively). Similarly, in the absence of PAA (Figure 2C), the
ARPE/HFF infection ratio of GT4_1 was significantly enhanced
when compared to GT1c_1 (p = 0.007), and both of GT4_1 and
GT4_2 when compared to GT1c_2 (p = 0.0005 and 0.0318),
respectively. Similarly as reported by Scrivano et al. (2011),
we also observed that the values obtained with this assay are
influenced by varying quality of cells and passage number.
Nevertheless, when plotting single assays (Figures 2B,D), the
pattern of enhanced epithelial tropism of both GT4 clones is
always maintained.
These data show that replacement of gO GT1c by gO GT4
results in a higher epithelial cell tropism and this most likely
leads to the higher release of infectious gO GT4 viruses than
gO GT1c viruses when the same MOI is used for epithelial cell
infection.
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FIGURE 3 | Infectivity of single cysteine mutants for fibroblasts and epithelial cells compared to the respective parental strains gO GT1c and gO GT4. Fibroblasts
(HFF) and epithelial cells (ARPE-19) were infected for 2 h with strains of the GT1c-group (A,B) or of the GT4-group (C,D) with 3.59 × 108 encapsidated genomes/ml,
which correspond to an MOI of 1 in GT1c_1. Luciferase assay was performed 48 h post infection and RLUs were determined in triplicates and three independent
experiments were performed. Error bars indicate SD. Mean RLUs of the mutants were compared individually to both respective parental clones. Mutants that are
significantly different to at least one of the two parental clones are marked by asterisks. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗∗p < 0.0001, unpaired two-tailed t-test.
Generation of a Set of Cysteine to Serine
Mutations in gO GT1c and gO GT4
Genotypic Background
Next, to gain more insight into gO genotype-dependent variances
we aimed to compare the phenotype of both gO genotypes
upon introduction of point mutations. Since mass spectrometry
and mutagenesis analysis of the trimeric gH/gL/gO complex
recently revealed that the amino acid residues gO-Cys-351 and
alternatively gO-Cys-226 (numbering according to gO GT5 of
Merlin strain) play important roles in trimer formation and/or
stability (Ciferri et al., 2015; Stegmann et al., 2016), we mutated
these highly conserved cysteines to serine in gO GT1c (C218S and
C343S) and gO GT4 (C216S and C336S), either individually or
in combination (Table 1 and Supplementary Figure 1). During
the course of reconstitution in HFFs from all newly generated
BAC mutant clones, the CPE was visually inspected by light
microscopy and the release of HCMV-DNA in supernatant was
measured by qPCR (Table 1). The genome sequence correctness
of all clones was confirmed before and after reconstitution.
Among all single cysteine mutants only the two gO
GT4-C336S clones displayed a CPE that differed from the
parental strain-like phenotype (even distribution over the whole
monolayer) in that only few scattered clusters of infected cells
were seen (Table 1). Virus stocks were harvested from the
supernatant 27–28 days post transfection when all cysteine
mutants reached comparable levels of HCMV-DNA. While also
the genome copy numbers of encapsidated HCMV-DNA were
similar among all single cysteine mutants, the TCID50/ml values
which were titrated on HFFs revealed a 2 log10 TCID50/ml lower
virus titer for the two gO GT4-C336S mutant clones compared
to parental strain gO GT4 (Table 1). Furthermore, the calculated
difference in mean log10 values between encapsidated genomes
and TCID50/ml was 5.10 and 5.15 for the GT4-C336S mutants,
while for all other strains it ranged from 2.45 to 3.49.
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TABLE 1 | Summary of gO genotype (GT) mutants.
Name of gO mutants Mutation of
gO1
CPE during
reconstitution in
HFFs
TCID50/ml
(log10)
Mean encapsidated
genomes/ml (log10)2
Difference mean
encapsidated-TCID50
in log10 values
GT1c_1 TB40-BAC4-
luc
Evenly spread 7.12 9.57 2.45
GT1c_2 TB40-BAC4-
luc
Evenly spread 6.60 9.84 3.24
GT4_1 Full-length
replacement
Evenly spread 6.57 9.80 3.23
GT4_2 Full-length
replacement
Evenly spread 6.57 9.54 2.97
GT1c-C343S_1 Single cysteine
to serine
Evenly spread 5.75 9.32 3.57
GT1c-C343S_2 Single cysteine
to serine
Evenly spread 6.60 9.66 3.06
GT4-C336S_1 Single cysteine
to serine
Clusters of infected
cells
4.50 9.60 5.10
GT4-C336S_2 Single cysteine
to serine
Clusters of infected
cells
4.50 9.65 5.15
GT1c-C218S Single cysteine
to serine
Evenly spread 6.39 9.19 2.80
GT4-C216S Single cysteine
to serine
Evenly spread 5.90 9.39 3.49
GT1c-C218/343S Double cysteine
to serine
Very few single foci No titer
determinable
nd nd
GT4-C216/336S Double cysteine
to serine
No CPE observed No titer
determinable
nd nd
1See Supplementary Information for more detailed sequence information.
2Mean of three quantifications by qPCR of three individual viral stock aliquots.
GT, genotype; gO, glycoprotein O; CPE, cytopathic effect; HFFs, human foreskin fibroblasts; TCID50, Fifty percent tissue culture infective dose; nd, not determined.
When both cysteine residues, C218 and C343 in GT1c or C216
and C336 in GT4, were mutated, no infectious particles could be
detected in supernatant upon reconstitution in HFFs. However, at
day 48 post transfection and after several rounds of cell reseeding,
the gO GT1c-C218/343S double mutant displayed single foci of
infected cells and this phenotype resembled the phenotype of
the gO deletion mutant (Jiang et al., 2008; Wille et al., 2010)
(Table 1). No viral titer was determinable and, hence, no further
experiments were performed with the double mutants.
Relative Infectivity of Single Cysteine
Mutants for Fibroblasts and Epithelial
Cells in gO GT1c and gO GT4
Background
Since the gO GT4-C336S mutants were severely reduced in
HFF-assessed viral titer despite normal amounts of encapsidated
genomes when compared to all other viral strains, this is
indicative that mutation of C336 in GT4 substantially affects
HFF infectivity. Thus, in a next step, we aimed to determine the
fibroblast and epithelial cell infection capacities of all cysteine
mutant viruses in comparison to their parental strains gO GT1c
and gO GT4, respectively. To this end, HFFs and ARPE-19
cells were infected with the same amount of encapsidated virus
genomes, corresponding to an MOI of 1 in gO GT1c, to ensure
that the same numbers of virus particles were used for the
parental and cysteine mutant strains. Infectivity was quantified by
monitoring luciferase expression in cell lysates 48 h post infection
as mentioned above and three independent experiments were
performed. As shown in Figures 3A,B and Table 2, while both gO
GT1c cysteine mutants, gO GT1c-C218S and gO GT1c-C343S,
displayed a similar infectivity for HFFs as their parental strains
GT1c_1 and GT1c_2, the mutation of C336S in gO GT4 led to
TABLE 2 | Summary of mean epithelial cell tropism.
Name of gO mutants Mean ARPE-19/HFF infection ratio in %
PAA− PAA+
GT1c_1 0.99 2.45
GT1c_2 0.80 3.29
GT4_1 5.83 6.05
GT4_2 2.72 7.26
GT1c-C343S_1 0.98 nd
GT1c-C343S_2 1.81 nd
GT4-C336S_1 16.44 nd
GT4-C336S_2 6.35 nd
GT1c-C218S 1.08 nd
GT4-C216S 1.72 nd
ARPE-19, adult retinal pigment epithelial cells; HFF, human foreskin fibroblasts; nd,
not determined.
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reduction in infectivity, which was significant when compared
to GT4_1 (p = 0.0025) and highly significant when compared
to GT4_2 (p < 0.0001). The markedly reduced infectivity of
gO GT4-C336S compared to parental strain GT4 corresponds
well to the above mentioned reduced virus titer despite normal
number of encapsidated genomes upon reconstitution in HFFs
(Table 1).
Also, the relative ARPE-19 cell infectivity was not significantly
affected by the single mutations, C218S and C343S, in gO
GT1c (Figure 3C). Notably, subtle differences might be masked
due to the rather high variability among distinct virus stocks
of GT1c and GT1c-C343S, respectively. In contrast, in the
background of gO GT4, both corresponding single mutants
GT4-C336S and GT4-C216S, displayed significantly reduced
infectivity (Figure 3D) compared to the parental strains gO
GT4_1 and GT4_2 with a reduction of 22–23% of mean log10
RLU caused by gO GT4-C216S (p < 0.005) and an even
higher reduction of 37% (GT4-C336S_1) to 44% (GT4-C336S_2)
attributed to the single point mutation C336S in GT4 (p< 0.005).
As shown in Table 2, the resulting ARPE-19/HFF ratios
were similar between the GT1c cysteine mutants and the two
parental gO GT1c clones. This contrasts to GT4 where the
mutation C216S led to a decrease in the ARPE-19/HFF ratio,
and C336S even caused an increase in epithelial cell tropism
when compared to their respective parental gO GT4 strains. This
indicates that despite an overall reduction of infectivity, the gO
GT4-C336S mutants retained an enhanced epithelial cell tropism.
Taken together, these data demonstrate that the impact of gO
cysteine mutations on cell-free infectivity for fibroblasts and
epithelial cells significantly differs between the two gO genotypic
backgrounds, GT1c and GT4.
Of note, the cell-free infectivity of the GT4 clones compared
to the GT1c clones was similar in fibroblasts (Figures 3A,B;
p = 0.17; ANOVA) showing a mean fold increase of 1.2 (range:
0.7–2.3) for GT4_1 and 1.8 (range: 1.0 – 2.6) for GT4_2.
The cell-free infection capacity for epithelial cells, however,
was significantly different between the GT4 and GT1c clones
(p= 0.0046; ANOVA) (Figures 3C,D). The mean fold increase in
epithelial cell infectivity was 7.0 (range: 3.2–12.2) for GT4_1 and
6.3 (range: 4.4–9.1) for GT4_2. These data are well in line with
the findings that gO GT4 strains displayed an enhanced epithelial
cell tropism as shown in Figure 2.
Content of gO and gH in Virions of gO
GT1c- and gO GT4 Mutants
Glycoprotein O appears to be present in the virions only in
a complex with gH/gL and it is suggested that the abundance
of gH/gL/gO correlates with the infectivity of the respective
virions (Murrell et al., 2013; Zhou et al., 2013, 2015). Thus,
we next determined whether the amount of gO and gH in
extracellular virions of parental and mutant gO GT1c and GT4
strains differed according to their varying infection capacities
as shown above. The gel loads for Western blot analyses under
reducing conditions were normalized to MCP which allowed to
compare the gO and gH content in the parental und mutant
HCMV virions. As shown in Figure 4A, the amounts of gO and
gH were similar between GT1c and GT4 with a trend toward
slightly higher gH in GT4 virions. Quantitative comparison
of gO levels among the cysteine mutant virions showed that
GT4-C336S contained the lowest amount of gO, followed by
GT1c-C343S, GT4-C216S, and GT1c-C218S (Figures 4B,C). The
severely reduced gO level in GT4-C336S virions corresponds
well with the pronounced infection defect as shown above.
Consistent with recent findings by Stegmann et al. (2016), the
rather low amounts of gO in GT1c-C343S appear to be sufficient
to maintain its proper infection capacities for fibroblasts and
epithelial cells. Also, the gH contents varied among the gO
cysteine mutants, yet the lowest gH levels were observed
in GT1c-C343S and not in GT4-C336S virions (Figure 4B).
These data indicate that mutation of the highly conserved gO
cysteine C343 in GT1c or the corresponding C336 in GT4
resulted in a substantial change in the gO and gH content,
the extent of reduction, however, depends on the gO genotypic
background.
Replication of gO GT1c-C343S and gO
GT4-C336S Mutants in Fibroblasts and
Epithelial Cells
Finally, we investigated how the cysteine mutations GT1c-C343S
and GT4-C336S affect the viral growth behavior in HFFs and
ARPE-19 cells in comparison to the corresponding parental
strains GT1c and GT4. Since in the previous experiments
differences in infectivity among our viral strains were detected
(Figures 2, 3), a preliminary dose finding experiment was
performed to normalize infectivity of GT1c, GT1c-C343S, GT4,
and GT4-C336S to 500–1500 RLUs at 48 h post infection in
both cell types individually. This allowed for a matched initial
infectivity for the growth curves of all four strains. Then,
both cell types were infected with the previously determined
virus dilutions (Supplementary Table 2), and cultured for 13
(HFFs) or 15 (ARPE-19) days. The kinetics of cell-free and cell-
associated HCMV-DNA were monitored at multiple time-points
post infection by qPCR (Figures 5A–D).
In HFFs, GT1c, GT1c-C343S, and GT4 displayed similar
levels of cell-free and cell-associated HCMV-DNA over the
entire time span, and comparable endpoint HCMV-DNA levels
(Figures 5A,B). The GT4-C336S mutant, on the other hand,
showed distinct HCMV-DNA kinetics. In the cell-free fraction,
the levels of HCMV-DNA of this mutant were elevated over the
first 6 days. This, however, might rather be explained by remnants
of the higher amounts of virions used for initial infection
(Supplementary Table 2) than by a new production of cell-free
HCMV-DNA, since no differences were observed when equal
amounts of encapsidated virions were used for initial infection
(see Supplementary Figure 1). Also, cell-associated HCMV-DNA
kinetics of GT4-C336S until day 10 were rather similar to that
of the other strains, independently of whether same amounts
of encapsidated virions or normalized infectivity was used for
initial infection, which further corroborates that the replication
efficiency in HFFs is comparable among all strains.
However, the GT4-C336S mutant showed substantially
reduced endpoint HCMV-DNA levels, both in the cell-free (1.0
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FIGURE 4 | Quantitative Western blots of purified virions. Virions were subjected to reducing gel electrophoresis and analyzed by Western blot using antibodies
directed against major capsid protein (MCP), and the glycoproteins gO (anti-gO antibody gO.02) and gH (anti-gH antibody AP86-SA4). The amounts of virions
loaded on the gels were normalized to equal amounts of MCP. First, the parental strains GT1c and GT4 were compared with each other (A). Next, the four mutants
were MCP-adjusted to each other and compared for content of gO and gH (B). Additionally, the mutants GT1c-C343S and GT4-C336S were analyzed using
increased amounts of virions for better detection of gO (C). Band densities were determined relative to one reference band for each blot individually, and are shown
below the blots. Mass markers are indicated on the left in kilodalton (kDa).
log10 copies/ml difference) and in the cell-associated (0.6 log10
copies/ml difference) fraction (Figures 5A,B). Since only the
initial infectivity could be normalized, it is most likely that in
subsequent rounds of infection the reduced fibroblast infection
capacity of GT4-C336S virions caused reduced endpoint HCMV-
DNA levels. Also, the CPE at day 13 post infection was clearly
distinct in that the infected cells remained restricted to single foci
(Figure 5E). All other strains displayed the characteristic CPE
with swollen cells and cell syncytia that were spread over the
entire cell monolayer.
In ARPE-19 cells, cell-free HCMV-DNA loads in the
early phase post infection were again not uniform between
the viral strains due to variety in applied virus amounts
(Figure 5C and Supplementary Table 2). Of note, no
differences in early viral loads were seen when the initial
infection was performed with equal amounts of encapsidated
virions (Supplementary Figure 1). At day 9 and later, similar
amounts of cell-free HCMV-DNA were detected for all strains.
GT1c, GT1c-C343S, and GT4-C336S yielded comparable
endpoint DNA loads, while GT4 was slightly elevated,
corresponding to the result seen in Figure 2. Further, no
differences between the strains could be observed in the cell-
associated HCMV-DNA kinetics (Figure 5D) indicating similar
replication dynamics with all four virus strains. Further, all
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FIGURE 5 | Replication and cytopathic effect of gO GT1c-C343S and gO GT4-C336S mutants. Fibroblasts (HFF) and epithelial cells (ARPE-19) were infected with
the mutants GT1c-C34S and GT4-C336S, and their respective parental strains GT1c and GT4 at an MOI normalized to 1000–1500 RLU at 48 h post infection.
Infected cells were cultured for 13 (HFF) or 15 (ARPE-19) days. At the indicated time points cell-free (A,C) and cell-associated (B,D) viral loads were assessed by
qPCR. Shown are mean values of three replicates; error bars indicate SD. In (E) representative light microscopy pictures of the cytopathic effect of GT1c, GT4 and
mutants are shown as seen in HFFs at day 13 and ARPE-19 at day 15 post infection. Infected HFFs of gO GT4-C336S are marked by a red, dashed line.
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four strains induced a similar CPE at day 15 post infection
(Figure 5E).
Taken together, these data indicate that the marked
impairment in cell-free fibroblast infectivity of the gO GT4-
C336S mutant leads to an attenuated growth phenotype with
lower endpoint HCMV-DNA levels and the observed CPE
pattern. On the other hand, the retained epithelial cell tropism
(Table 2) allows the GT4-C336S mutant to grow in a similar
fashion as its parental strain GT4, indicating that the cell-to-cell
spread is not affected. The corresponding cysteine mutation
in the background of gO GT1c, yet shows a GT1c-like growth
phenotype in both cell types. This further underlines that these
single cysteine mutations in gO GT1c do not substantially impact
the function of gO despite the substantial reduction of the gO
content in GT1c-C343S virions as shown above.
DISCUSSION
In the present study, we show that two identical HCMV strains
that differ solely in the gO genotype sequence, either gO GT1c
or gO GT4, display significant differences in epithelial cell
tropism. We further demonstrate that single point mutations of
two strictly conserved cysteines of gO, known to be important
for gH/gL/gO trimer formation and/or stability, differentially
impair cell-free infectivity for fibroblasts and epithelial cells
depending on the gO genotype background in which they were
mutated.
First, we could show that the TB40-BAC4-luc-derived mutant
virions with full-length replacement of gO GT1c by GT4 ORF
sequence of Towne strain (gO GT4 mutants) retained the ability
to infect both fibroblasts and epithelial cells. This suggests that
the basic functional nature of gO is similar between distinct
gO genotypes and this is well in concordance with the findings
that all gO genotypes can form stable gH/gL/gO trimers and
that different HCMV strains, each of which carrying a distinct
gO genotype, also contain the trimeric complex in their virions
(Zhou et al., 2013).
Detailed comparison of the infection behavior of gO GT4
mutant viruses compared to parental strain TB40-BAC4-luc
(gO GT1c viruses) revealed that gO GT4 mutants displayed a
significantly higher epithelial cell tropism than gO GT1c viruses.
Despite a rather high variation in the epithelial cell to fibroblast
infection ratio between experiments, this phenotype was always
seen in a set of 3–6 independent experiments and this was
proven for two independently generated gO GT4 mutant virus
clones. Besides, similar results were obtained in the presence
and absence of the replication inhibitor PAA indicating that the
observed differences in epithelial cell infectivity were not due
to potential differences in replication. This finding was further
supported by the observation that gO GT4 viruses showed a more
than sixfold increase in their capacity to infect epithelial cells
compared to gO GT1c when from both, gO GT1c and gO GT4
viruses, the same number of encapsidated HCMV DNA genomes
was used for infection. Furthermore, we confirmed by whole
genome sequencing that no other mutations emerged during the
course of reconstitution. Thus, it is strongly suggested that the
observed differences in epithelial cell infectivity are attributed to
sequence differences between gO GT1c and gO GT4 (Figure 6).
Notably, of all gO GT sequences, GT4 is the most diverse to GT1c,
sharing only 78% identity in codon sequence, and therefore was
chosen for gO GT replacement. The GT1c and GT4 sequences
differ most at the N-terminus and in the central part of gO,
and further inspection for predicted N- and O-glycosylation sites
using the web-based programs NetNGlyc 1.0 and NetOGlyc 4.0,
respectively, revealed a substantial difference in the number of
predicted N-glycosylation (15 sites in GT1c vs. 11 in GT4) and
O-glycosylation sites (27 in GT1c vs. 18 in GT4) between the two
genotypes. Most of the putative O-glycan sites are found in the
central part of gO (Figure 6) which also includes a prominent
hydrophilic stretch that is less hydrophilic in GT4 than in GT1c
(Paterson et al., 2002; Mattick et al., 2004; Zhou et al., 2013).
Hence, it is very likely that the specific sequence properties of
GT1c and GT4 may differentially influence the function of gO.
In virions, gO is found in the envelope in a complex with
the heterodimer gH/gL (Huber and Compton, 1998). Recent
studies have revealed that gH/gL-C144 forms a covalent bond
either with gO or UL128 (Ciferri et al., 2015). The resulting
trimer to pentamer ratio of the virions appears to influence
the cell tropism, whereby the relative levels of the trimer and
pentamer can differ between distinct strains, influenced by the
expression levels of UL128-131 (Murrell et al., 2013; Zhou
et al., 2013, 2015), the viral regulator UL148 (Li et al., 2015),
the cell type producing the virion population (Scrivano et al.,
2011), and probably also by the gO genotype of the respective
strain (Zhou et al., 2013). TB40E-derived strain TB40-BAC4-
luc contains vastly more trimer than pentamer due to a UL128
intron mutation which as a consequence displays a cell-free
infection capacity that is low for epithelial cells and high for
fibroblasts (Murrell et al., 2013). Thus, firstly it is presumable
that replacement of TB40-BAC4-luc resident gO GT1c by GT4
caused a switch toward more pentamer and this could well
explain the observed increase in epithelial cell tropism, yet by
retaining enough trimer for efficient fibroblast infection. Our
data, however, show that both strains harbor comparable gO
levels in their extracellular virions which strongly suggests that
the amount of trimer did not differ between gO GT1c and gO
GT4. From our data it appears that the gO GT4 virions contain
slightly more gH than gO GT1c virions. If this indicates that gO
GT4 harbors more of the gH-containing pentamer complex than
gO GT1c yet awaits further clarification. Secondly, it cannot be
excluded that genotype-specific sequence properties differentially
affect a gO function that is played out by endocytosis-mediated
entry into epithelial cells only and not by fibroblast entry (Zhou
et al., 2015; Kabanova et al., 2016). Further investigations will
be necessary to clarify which parts of the heterogeneous gO
sequences contribute to functional differences and how these
properties might influence the formation and/or stabilization of
the trimer.
Interestingly, the enhanced epithelial cell infectivity of gO
GT4 viruses resulted in a slightly higher release of cell-free
viruses compared to GT1c as shown by growth curve analysis
on epithelial cells. Since HCMV transmission typically occurs
via a mucosal route, epithelial cells are supposed to be the
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FIGURE 6 | Comparison of gO GT1c and gO GT4 amino acid sequences. Reference sequences of genotype (GT) 1c (TB40BAC4; Protein ID: ABV71596.1) is
aligned with gO GT4 sequence of HCMV strain Towne (Protein ID: KF493877.1). Putative N-glycosylation sites as predicted by NetNGlyc 1.0 are indicated by black
boxes and putative O-glycosylation sites as predicted by NetOGlyc 4.0 are highlighted in gray. The black bar indicates the hydrophilic stretch as characterized
previously (Zhou et al., 2013). The asterisks show the cysteine residues, GT1c-C218 or GT4-C216, and GT1c-C343 or GT4-C336. The black triangle depicts the
O-glycosylation site identified by mass spectrometry (Bagdonaite et al., 2016).
first target cell type of HCMV infection and these, after viral
dissemination to other cell types, contribute to viral shedding
into body fluids (Mocarski, 2013). Thus, it is tempting to
speculate that the production of more virions by GT4 in
combination with an enhanced cell-free infectivity might have
clinical consequences either in viral shedding and/or in the
ability of the virions for transmission to another host. However,
it has to be considered that all known gO genotypes can be
found in clinical samples, yet the frequency of occurrence
may differ among distinct gO genotypes (Rasmussen et al.,
2003; Mattick et al., 2004; Stanton et al., 2005; Puchhammer-
Stöckl et al., 2006; Yan et al., 2008; Görzer et al., 2010, 2015;
Chen et al., 2016). Moreover, it is assumed that numerous
different HCMV strains circulate in the human population,
each characterized by a specific combination of genotypes
when all polymorphic genome regions are taken into account
(Puchhammer-Stöckl and Görzer, 2011; Sijmons et al., 2015).
Thus, it is likely that the infection behavior of an HCMV
strain does not solely rely on the functional properties of a
unique genotype but rather on a certain genotype combination.
However, specific functional features of an individual genotype
may either be masked or enhanced depending on its overall
genotype-combination and this needs to be explored in further
investigations.
Recent mass spectrometry and mutagenesis analysis of HCMV
gH/gL/gO revealed that gL-C144 forms a disulfide bond with gO
GT5-C351 and may alternatively form a disulfide bond with gO
GT5-C226 (Ciferri et al., 2015). In the present study, we also
focused on these two strictly conserved gO cysteines and we
compared how a mutation to serine affects infection and growth
on epithelial cells and fibroblasts either in gO GT1c (C218S
and C343S) or in gO GT4 (C216S and C336S) in an otherwise
identical HCMV TB40-BAC4-luc genomic background. Our
data show that none of the two single cysteine mutations in
gO GT1c background led to an explicit change in cell-free
infectivity and this is well in agreement with the findings
recently published by Stegmann et al. (2016). Remarkably,
this is in sharp contrast to gO GT4 in which both of the
corresponding cysteine mutations (C216S or C336S) provoked
a reduction in cell-free infectivity. Particularly, the strong
difference between the gO GT1c-C343S and gO GT4-C336S
infection phenotypes was further underlined by their divergent
growth curve kinetics on fibroblasts and by their markedly
different CPE. We could further show that the mutation of
C336 in GT4 causes a more severe reduction in the virion’s
gO content than the corresponding C343 mutation in GT1c.
And this is well in line with the different infection capacities of
these two cysteine mutants. Since, the gO cysteine residues are
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strictly conserved among the gO genotypes, it is very likely that
specific sequence properties of gO GT1c and GT4 as described
above differentially influence the compensation of a cysteine loss.
Collectively, these findings provide strong indirect evidence that
gO GT1c and GT4 differ in their functional behavior.
An interesting finding was that gO GT4-C216S caused only a
moderate reduction in infectivity which was played out mainly
on epithelial cells whereas the mutation of GT4-C336S led to
about 40% impairment in cell-free infectivity for both cell types.
This indicates that C336 plays a much more prominent role
in maintaining the proper function of gO GT4 than C216 and
this is clearly reflected by the much smaller amount of gO in
the extracellular virions of GT4-C336S compared to GT4-C216S.
Interestingly, the gH content only slightly differs between these
two cysteine mutants. Thus, the relatively high gH content in
the gO GT4-C336S virions might reflect more pentamer in the
virions and this would well explain why gO GT4-C336S displayed
a substantial increase in epithelial to fibroblast infection ratio
despite an overall impairment in cell-free infectivity for both cell
types.
Finally, we could also show that simultaneous mutation of
both cysteines to serine almost completely abolished viral growth
in the two distinct gO genotypic backgrounds. This indicates
that for both gO GT1c and gO GT4 at least one of these highly
conserved cysteines has to be present. The phenotype of the
double mutants resembled that of the gO deletion mutant (Jiang
et al., 2008; Wille et al., 2010; Scrivano et al., 2011; Laib Sampaio
et al., 2016; Stegmann et al., 2016), and this is most likely due
to disruption of the trimer as recently reported (Stegmann et al.,
2016).
CONCLUSION
The phenotypic characterization of a set of gO mutants
demonstrates that gO GT1c and gO GT4 differ in their
functional properties which seem to influence HCMV epithelial
cell tropism and this may have important implications on virus
host transmission.
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